Lumira Ventures partners with exceptional entrepreneurs to build life science companies that transform the lives of patients worldwide.

Lumira News

Medexus Reports Increased Revenues of C$16.2M for Q3 2020

February 19, 2020
TORONTO and CHICAGO and MONTREAL (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) today provided a business update and announced... Learn More

Antios Therapeutics Initiates First-in-Human Phase 1 Study of ATI-2173

February 12, 2020
ATLANTA /PRNewswire/ -- Antios Therapeutics, Inc. ("Antios"), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure viral diseases,... Learn More

Bardy Diagnostics™ Commercially Launches its 14-Day CAM™ Patch

January 23, 2020
SEATTLE /PRNewswire/ -- Bardy Diagnostics, Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today the commercial launch of... Learn More

Opsens Receives FDA Approval for Optowire III

January 14, 2020
QUEBEC CITY /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) today announced 510(k) clearance from the U.S. Food and Drug Administration ("FDA") to market... Learn More

Team Lumira

Our investment team of 9 professionals has over 225 years of collective experience founding, managing and investing in healthcare and life sciences companies. We value collaboration, creativity and challenging conventional wisdom.

MEET THE TEAM
Image

Philanthropy

Lumira donates a portion of partner time and profits to support the research, translational medicine and healthcare access missions of over a dozen leading healthcare foundations.

LEARN MORE
  • “Lumira’s philanthropic vision of leveraging research, resources and knowledge to improve the lives of patients will strengthen St. Michael’s ability to accelerate the pace.”

    Dr. Arthur Slutsky | Vice-President
    Vice-President of Research at St. Michael’s Hospital
  • “Lumira’s model provides a new pathway for philanthropy to partner with investors in advancing healthcare innovation.”

    Barbara Grantham | President & Ceo
    VGH & UBC Hospital Foundation
  • “This distinctive approach to supporting innovation is very creative, very much needed and very much appreciated by Princess Margaret and University Health Network.”

    Paul Alofs | President & Ceo
    Princess Margaret Cancer Foundation

Contact Us

Our team is strategically situated across North America to identify innovative companies within and outside the traditional start-up hubs, and help them access capital, talent and strategic partners.

Image

Toronto

141 Adelaide Street
Suite 770
Toronto, ON
Canada, M5H 3L5
416.213.4223

Image

Montreal

Espace CDPQ
3, Place Ville Marie
Bureau 12350, Niveau L
Montreal, QC
Canada, H3B 0E7
514.844.6927

Image

Vancouver

1021 West Hastings Street,
9th floor
Vancouver, BC
Canada, V6E 0C3
604.558.5156

Image

Boston

303 Wyman Street
Suite 300
Waltham, MA,
USA, 02451-1208
781.530.3868